The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 20, 2023

Filed:

Nov. 23, 2018
Applicants:

Institut National DE LA Santé ET DE LA Recherche Médicale (Inserm), Paris, FR;

Assistance Publique—hôpitaux DE Paris, Paris, FR;

Université Paris-saclay, Saint-Aubin, FR;

Université Paris Cité, Paris, FR;

Inventors:

Frank Griscelli, Villejuif, FR;

Ali Turhan, Villejuif, FR;

Annelise Bennaceur Griscelli, Villejuif, FR;

Christophe Desterke, Villejuif, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/12 (2015.01); A61K 35/13 (2015.01); A61K 35/545 (2015.01); A61K 31/19 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01); A61K 39/39 (2006.01);
U.S. Cl.
CPC ...
A61K 39/00118 (2018.08); A61K 31/19 (2013.01); A61K 39/39 (2013.01); A61P 35/00 (2018.01); A61K 2039/515 (2013.01);
Abstract

The inventors provide a new therapeutic strategy to treat cancers expressing embryonic antigens. Accordingly, the present invention relates to a method of treating a subject suffering from a cancer comprising a step of administration simultaneously, separately or sequentially to said subject a therapeutically amount of i) a population of derived engineered fetal stem cells carrying cancer associated fetal neo-antigen and ii) a compound selected from a group which activates immune response, as a combined preparation.


Find Patent Forward Citations

Loading…